Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 4/20 | 0.35 |
| ▸ | PPARG | P37231 | 3/20 | 0.35 |
| ▸ | PPARD | Q03181 | 3/20 | 0.35 |
| ▸ | GRM5 | P41594 | 5/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CDC25A | P30304 | 1/20 | 0.33 |
| ▸ | CDC25B | P30305 | 1/20 | 0.33 |
| ▸ | CDC25C | P30307 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 3/20 | 0.32 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13572451 | 0.92 | GRM5 (0.38) | PPARAPPARGPPARDGRM5MEN1 | |
| SCHEMBL13572446 | 0.89 | MCHR1 (0.35) | PPARAPPARGPPARDMEN1KMT2A | |
| SCHEMBL14706338 | 0.82 | GAA (0.38) | PPARAPPARGPPARDMEN1KMT2A | |
| SCHEMBL14706551 | 0.82 | MEN1 (0.41) | PPARAPPARGPPARDGRM5MEN1 | |
| SCHEMBL13572450 | 0.81 | ALDH1A1 (0.33) | PPARAPPARGPPARDMEN1KMT2A | |
| SCHEMBL13572449 | 0.81 | MAPT (0.36) | PPARAPPARGPPARDGRM5MEN1 | |
| SCHEMBL14706337 | 0.78 | THRA (0.35) | PPARAPPARGPPARDCNR2ALDH1A1 | |
| SCHEMBL14706336 | 0.77 | PPARG (0.36) | PPARAPPARGPPARDMEN1KMT2A | |
| SCHEMBL14706340 | 0.77 | MCHR1 (0.32) | PPARAPPARGPPARDCDC25ACDC25B | |
| SCHEMBL6793004 | 0.75 | ALDH1A1 (0.32) | PPARAPPARGPPARDCDC25ACDC25B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8378336-B2 | Liquid crystalline organic semiconductor material and organic electron device | FUJIFILM CORPORATION (JP) | 2013-02-19 | — | — | US | disclosed |
| US-20090315025-A1 | LIQUID CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC ELECTRON DEVICE | FUJIFILM CORPORATION (JP) | 2009-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090315025-A1 | LIQUID CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC ELECTRON DEVICE | NONO, OCIAD2, PNN | PPARA 3916/4885PPARG 3569/4885PPARD 2934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.